Review Article

10 Practice Recommendations in Adult Vaccination Administration

Authors: Benjamin J. Oldfield, MD, Rosalyn W. Stewart, MD, MS

Abstract

Although the provision of immunoprophylaxis to children has become routine in the practice of pediatric preventive care, the same is not true in adult primary care. Contributing to this problem is a lack of knowledge among providers of adult preventive care. This review aimed to bolster providers’ understanding of adult vaccinations by highlighting changes in vaccination recommendations and addressing common knowledge gaps. This is not a comprehensive list of vaccination recommendations, but rather the ‘‘top 10’’ common misconceptions, advancements, and updates we have found in our reading of the vaccination literature and in our own experience in a training institution.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. US Department of Health and Human Services. Data2010Ithe Healthy People 2010 Database. http://wonder.cdc.gov/data2010/obj.htm. Accessed July 24, 2015.
 
2. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged Q65 years--United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:532-537.
 
3. Marin MG, Johanson WG, Salas-Lopez D. Influenza vaccination among minority populations in the United States. Prev Med 2002;34:235-241.
 
4. Williams WW, Hickson MA, Kane MA, et al. Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med 1988;108:616-625.
 
5. Merkel PA, Caputo GC. Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate. J Gen Intern Med 1994;9:679-683.
 
6. Zimmerman RK, Silverman M, Janosky JE, et al. A comprehensive investigation of barriers to adult immunization: a methods paper. J Fam Pract 2001;50:703.
 
7. Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin Infect Dis 2007;44:1532-1535.
 
8. Elkin Z, Cohen EJ, Goldberg JD, et al. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination. Cornea 2013;32:976-981.
 
9. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:9-31.
 
10. Centers for Disease Control and Prevention. Pertussis--United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002;51:73-76.
 
11. Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the United States. Pediatrics 2015;136:635-641.
 
12. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:261-278.
 
13. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:187-207.
 
14. Kim DK, Bridges CB, Harriman KH, et al. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015. MMWR Morb Mortal Wkly Rep 2015;64:91-92.
 
15. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2012;61:816-819.
 
16. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:231-243.
 
17. Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006;24:572-577.
 
18. Centers for Disease Control and Prevention. CDC Health Information for Internal Travel. New York: Oxford University Press; 2012.
 
19. Gergen PJ, McQuillan GM, Kiely M, et al. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-766.
 
20. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Hamborsky J, Kroger A, Wolfe S, eds. Washington, DC: Public Health Foundation; 2015:341-352.
 
21. McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2013;62(RR-04):1-34.
 
22. Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014;58:e1-e34.
 
23. Kroger AT, Sumaya CV, Pickering LK, et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(RR-02):1-60.
 
24. Advisory Committee on Immunization Practices, Fiore AE, Wasley A, et al. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-7):1-23.